Unanet | January 06, 2022
Unanet, the leading provider of project-based ERP for the government contractor (GovCon) industry, announced today that OneZero Solutions, a cybersecurity powerhouse, has selected Unanet ERP GovCon to help it better integrate its project management system, and support the in-depth, detailed reporting required by government agencies.
OneZero started in Cybersecurity Operations, but has grown its array of offerings to include Enterprise IT Managed Services, Full-Stack Development, and Data Analytics in its three short years in existence. This growth exposed the need for a more comprehensive ERP system, especially for payroll, accounting and financial management of labor and projects.
"Our government contracts need more in-depth reporting, coding, and details than our payroll software can provide. "We need the ability to run reports that meet our federal agency customers' requirements, and to have a system that will continue to grow and scale with us."
Veronica Williams, OneZero's director of corporate operations
Once implemented, Unanet will give OneZero a variety of benefits it needs to succeed in the growing cybersecurity and GovCon industries. Those include:
Simplicity in making salary and pay adjustments
Specialized reporting and views of different billing rates by project and staffer
Improved integration and ease-of-use for accounting partners
Elimination of cumbersome and unreliable spreadsheets across the business.
Many emerging companies like OneZero select Unanet GovCon ERP because it has the right mix of functionality and accessibility, while also offering the ability to scale and grow seamlessly.
Unanet is a leading provider of project-based ERP and CRM solutions purpose-built for Government Contractors, architecture, engineering, construction, and professional services. More than 3,400 project-driven organizations depend on Unanet to turn their information into actionable insights, drive better decision-making, and accelerate business growth. All backed by a people-centered team invested in the success of your projects, people, and financials.
Merck | December 22, 2021
Merck , known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics today announced that the United Kingdom Government will purchase an additional 1.75 million patient courses of molnupiravir (MK-4482), an investigational oral antiviral COVID-19 medicine. In the U.K., LAGEVRIO® is the planned trademark for molnupiravir; the trademark for molnupiravir in other countries has not been approved. With this additional procurement agreement, which follows a previously announced agreement for 480,000 courses of treatment, the U.K. Government has now committed to purchase a total of 2.23 million courses of molnupiravir.
In early November, molnupiravir received conditional marketing authorization in the U.K. for the treatment of mild to moderate COVID-19 in adults with a positive SARS-CoV-2 diagnostic test and who have at least one risk factor for developing severe illness. Molnupiravir is currently available in the U.K. and patients have started to receive treatment. An application for Emergency Use Authorization for molnupiravir is under review by the U.S. Food and Drug Administration.
Merck has entered into advance purchase and supply agreements for molnupiravir with governments of more than 30 countries worldwide, including 21 agreements with countries in Europe.
About Merck’s Global Efforts to Accelerate Access to Molnupiravir Following Regulatory Authorizations or Approvals
Global access has been a priority for Merck and Ridgeback since the inception of their molnupiravir collaboration. The companies are committed to providing timely access to molnupiravir globally through our comprehensive supply and access approach, which includes investing at risk to produce millions of courses of therapy; tiered pricing based on the ability of governments to finance health care; entering into supply agreements with governments; and granting voluntary licenses to generic manufacturers and to the Medicines Patent Pool to make generic molnupiravir available in more than 100 low- and middle-income countries following local regulatory authorizations or approvals.
Supply: In anticipation of the results from MOVe-OUT and the potential for regulatory authorization or approval, Merck has been producing molnupiravir at risk and expects to produce 10 million courses of treatment by the end of 2021, with at least 20 million courses to be produced in 2022. To date, Merck has shipped molnupiravir to 12 countries; in countries where it is approved or authorized, patients have begun to receive the drug.
Supply agreements: Merck entered into a procurement agreement with the U.S. Government under which the company will supply approximately 3.1 million courses of molnupiravir to the U.S. Government, upon Emergency Use Authorization or approval from the U.S. Food and Drug Administration. Merck has entered into advance purchase and supply agreements for molnupiravir with governments for over 30 countries worldwide, including Australia, Canada, Korea, Japan, Thailand, United Kingdom and United States, pending regulatory authorizations, and is currently in discussions with additional governments. Merck plans to implement a tiered pricing approach based on World Bank country income criteria to reflect countries’ relative ability to finance their health response to the pandemic.
Voluntary licenses: As part of its commitment to widespread global access, Merck previously announced that it has entered into a licensing agreement with the Medicines Patent Pool to increase broad access for molnupiravir in low- and middle-income countries. Additionally, Merck previously announced that the company has entered into non-exclusive voluntary licensing agreements for molnupiravir with established generic manufacturers to accelerate availability of molnupiravir in more than 100 low- and middle-income countries following approvals or emergency authorization by local regulatory agencies.
Merck continues to discuss additional measures and collaborations to accelerate broad, global access to molnupiravir.
Molnupiravir (MK-4482) is an investigational, orally administered form of a potent ribonucleoside analog that inhibits the replication of SARS-CoV-2, the causative agent of COVID-19. Molnupiravir has been shown to be active in several preclinical models of SARS-CoV-2, including for prophylaxis, treatment, and prevention of transmission. Pre-clinical data suggest that molnupiravir has a high barrier to the development of resistance.
HawkEye 360 | January 11, 2022
HawkEye 360 Inc., the world's leading commercial provider of space-based radio frequency (RF) data and analytics, today announced it has been awarded a three year, $15.5 million Experimental Purpose Agreement (EPA) contract with the Air Force Research Laboratory's (AFRL) Space Vehicles Directorate. Through the agreement, HawkEye 360 will provide radio frequency analytics research, development, and experiments to help the government demonstrate, test and evaluate its hybrid space ISR architecture.
"This agreement is a tremendous opportunity for HawkEye 360 to showcase the whole spectrum of capability we offer the government as it develops its space architectures," said CEO John Serafini. "We deliver value not only through the efficient tasking, collection and delivery of our RF data, which has never before been commercially available, but also through embedded operational support and enhanced analytics capabilities, deriving applicable insights for diverse end users. Ultimately, we hope to shape a pathway for further integration of valuable commercial capabilities into the government's space architecture."
HawkEye 360 has previously supported numerous Air Force Research Laboratory exercises, but had never done so through a direct contract vehicle. As part of the new agreement, HawkEye 360 will support a variety of operational use cases by providing embedded personnel support, data collection, tools for data ingestion, analytics and more. The agreement scope includes participating military exercises, such as the Rim of the Pacific Exercises, to introduce new capabilities to the warfighter and identify ways to improve and integrate into operational workflows.
The EPA contract vehicle is available for use by all Combatant Commands as they look to test and demonstrate innovative commercial RF data and analytics to include Direct Downlink to government ground stations.
"We appreciate the opportunity to partner with one of the most prestigious military research organizations in the world," said Alex Fox, Executive Vice President for Global Growth. "Our team is excited to be part of an AFRL program focused on developing and transitioning space capabilities for more effective and affordable warfighter missions. We share AFRL's vision for a hybrid government and commercial ISR architecture to address growing global threats and to provide the warfighter with high-impact insights needed to support their mission."
"The Department of Defense constantly seeks to identify, evaluate and recommend commercial intelligence, surveillance, and reconnaissance capabilities for integration into United States Air Force and United States Space Force workflows," said AFRL Technical Program Manager Charlene Jacka. "We are pleased to have the opportunity to explore at greater scale and depth, using real-world scenarios, how a leading radio frequency data and analytics provider such as HawkEye 360 can supplement and strengthen our hybrid satellite ISR architecture, and to develop new tactics, techniques and procedures to enable further utility assessments."
HawkEye 360 operates a growing constellation of satellites which detects, characterizes and precisely geolocates radio frequency signals from a broad range of emitters used for communication, navigation and security. By processing and analyzing this RF data, the company delivers high-impact actionable insights across a broad range of sectors, including environmental protection and national security.
About Hawkeye 360
HawkEye 360 is a Radio Frequency (RF) data analytics company. We operate a first-of-its-kind commercial satellite constellation to identify, characterize, and geolocate a broad set of RF signals. We extract value from this unique data through proprietary algorithms, fusing it with other sources to create powerful analytical products that solve hard challenges for our global customers. Our products include maritime domain awareness and spectrum mapping and monitoring; our customers include a wide range of commercial, government and international entities.
Ioterra | December 18, 2021
Ioterra, the marketplace for IoT development, has been selected from a competitive process to be part of a corporate delegation that the Nevada State government will be sending to Dubai for the largest governmental trade mission of 2022. Representatives from Ioterra will be visiting Dubai between March 2-10, 2022 to explore partnerships with high-tech innovation and digital transformation organizations in Dubai. The intent of the trade mission is to foster more business exchange between the US and the UAE.
The trade mission is the Trade Winds Mission and Business Forum. Organized by the U.S. Commercial Service, Trade Winds will involve U.S. commercial diplomats from over 20 countries in the Middle East, North Africa and Sub-Saharan Africa. The stated purpose of Trade Winds is to help US companies achieve growth and exposure in specific strategic markets around the world. The upcoming 2021 conference is to be held at the InterContinental Festival City in Dubai. Following the primary Trade Winds conference, Ioterra was additionally selected to participate in a Mission Stop in Riyadh, Saudi Arabia to assess the potential of setting up an IoT channel partnership with select organizations in the region.
Ioterra is a marketplace platform of deals, services, and resources for product development. The Ioterra platform has 8,000+ users, hundreds of sellers, and has supported the launch of millions of product units into the field. Check out www.ioterra.com to learn more about the platform. The Ioterra platform currently has presence in North America, South America, Europe, China, and India. With the upcoming Trade Winds mission, Ioterra will seek to set up strategic partnerships that will bring critical IoT and Industry 4.0 innovations to the Middle East, North Africa, and Sub-Saharan Africa.